STAT Plus: Debates over biosimilar uptake notwithstanding, sales growth should accelerate by 2024
Despite various issues that have slowed biosimilar uptake by the U.S. health care system, usage…
Category: bioisimilars
Despite various issues that have slowed biosimilar uptake by the U.S. health care system, usage…